Labiotech.eu

News and Trends 8 Mar 2023

Women in STEM: challenges and opportunities

In this article to celebrate International Women’s Day, we asked women in STEM for their comments on the challenges they have faced in their careers so far, and how solutions can emerge from these challenges. We get advice from Fiona McLaughlin, CSO, Avacta Therapeutics; Maureen Coleman, chairman, CN Bio; Debora Lucarelli, CEO, Enhanc3D Genomics; Tamsin […]

March 8, 2023 - 14 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

How to encourage more women in life science jobs

In this article to celebrate International Women’s Day, we asked six women biotech professionals for their observations on women in the life sciences industry. We spoke to Sheelagh Frame, CSO, Ubiquigent; Debora Lucarelli, CEO, Enhanc3D Genomics; Charli Batley, COO, Phoremost; Tamsin Mansley, president, Optibrium Inc. and global head of application science, Optibrium; Maureen Coleman, chairman, […]

March 8, 2023 - 8 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

The challenges of tackling dementia in women

Dr Andrea Pfeifer, chief executive officer of AC Immune SA, talks to Labiotech about dementia research, and how dementia affects women. She also addresses how vital research is when it comes to addressing women’s health. Dementia is a leading cause of death in women, but it doesn’t get the attention of other diseases, such as […]

March 8, 2023 - 5 minutesmins - By Jim Cornall

Best in Biotech 8 Mar 2023

5 female-led biotech startups making waves

International Women’s Day takes place on March 8, which celebrates the achievements of women, and also shines a light on gender discrimination and the need to accelerate gender parity. Although the percentage of women in the life sciences industry as a whole is almost equal to that of men, there is still work to be […]

March 8, 2023 - 6 minutesmins - By Willow Shah-Neville

Interview 8 Mar 2023

Phacilitate’s Women in Advanced Therapies program supports women in science

Marlin Frechette is the chief quality and compliance officer at FUJIFILM Irvine Scientific. But she has another role. Frechette is also a member of Phacilitate’s Women in Advanced Therapies program, and was formerly a mentor, and she tells us here how the program supports women in executive level life science roles. Frechette takes up the […]

March 8, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 6 Mar 2023

10 universities around the world to study biotech you should know about

The biotech industry across the world has been picking up its pace over the years. As many sectors plummeted during the pandemic, the biotechnology industry weathered the storm. Global biopharma companies are collaborating with biotechnology universities across the globe to improve research and development in various fields within the industry. To boost business opportunities, universities […]

March 6, 2023 - 8 minutesmins - By Roohi Mariam Peter

In Depth 6 Mar 2023

The biggest private biotech investments in February 2023

The companies Aera Therapeutics, Hemab and Loam Bio bagged the biggest biotech investments in February 2023. Around the world, gene therapy, manufacturing and biomaterials attracted the most investor interest. Private biotech fundraising in February 2023 lacked the massive funding rounds seen in January, from the likes of Asimov and BioRay Pharmaceuticals. However, there was still […]

March 6, 2023 - 4 minutesmins - By Jonathan Smith

News and Trends 3 Mar 2023

Beyond Biotech podcast 36: Bio-Europe Spring and Cellular Origins

Two of the interviews on the podcast today are related to Bio-Europe Spring. There are conversations with Rosie Bernard, senior director, production and content strategy for EBD Group EU, with an overview of the event, and also Jordan Stillman, project manager, partnering services at EBD Group. We also have a chat with Cellular Origins’ CEO […]

March 3, 2023

Interview 3 Mar 2023

Interview: how has the first gene therapy for hemophilia B transformed research?

Hemophilia B, a rare disease that affects more than 230,000 people worldwide is caused by the lack of or defective clotting protein factor IX often due to a spontaneous mutation in the F9 gene, leading to excessive bleeding. Until recently, routine prophylactic infusions of factor IX replacement therapy to maintain enough clotting factor to prevent […]

March 3, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 3 Mar 2023

Lilly to develop Confo pain drug

Confo Therapeutics, which works on the discovery of medicines targeting G-protein coupled receptors (GPCRs), has announced a worldwide licensing agreement with Eli Lilly and Company for Confo’s clinical stage CFTX-1554 and back-up compounds. CFTX-1554, a novel inhibitor of the angiotensin II type 2 receptor (AT2R) is currently in phase 1 clinical development. It represents a […]

March 3, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 3 Mar 2023

Porton and DanausGT look to boost development of gene and cell therapy

Porton Advanced Solutions Ltd. and DanausGT Biotechnology Co., Ltd. have announced a strategic collaboration in gene and cell therapy pipelines to expedite the development of innovative therapeutics. As an end-to-end gene and cell therapy service provider, Porton Advanced CDMO offers solutions covering plasmids, cell therapy, gene therapy, oncolytic viruses, mRNA therapy, and bacterial therapy. DanausGT […]

March 3, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 3 Mar 2023

Debiopharm adds to oncology pipeline

Debiopharm, an independent Swiss-based, biopharmaceutical company, has obtained the global rights for FT-3171, a small molecule USP1 inhibitor program targeting a novel DNA damage repair (DDR) pathway from Novo Nordisk. FT-3171 was developed by Forma Therapeutics, which was acquired by Novo Nordisk in 2022, and is currently in late preclinical development. FT-3171 (Debio 0432) could […]

March 3, 2023 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Women in STEM: challenges and opportunities

How to encourage more women in life science jobs

The challenges of tackling dementia in women

5 female-led biotech startups making waves

Phacilitate’s Women in Advanced Therapies program supports women in science

10 universities around the world to study biotech you should know about

The biggest private biotech investments in February 2023

Beyond Biotech podcast 36: Bio-Europe Spring and Cellular Origins

Interview: how has the first gene therapy for hemophilia B transformed research?

Lilly to develop Confo pain drug

Porton and DanausGT look to boost development of gene and cell therapy

Debiopharm adds to oncology pipeline

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!